Flow cytometry intracellular staining of human PHA stimulated and Brefeldin A treated peripheral whole blood staining IL-17A with Anti-IL-17A Antibody [9F9] (A320757), (concentration in sample 0,5 µg/ml, GAM APC).
Separation of human CD4 positive IL-17A positive lymphocytes (red-filled) from CD4 negative IL-17A negative lymphocytes (black-dashed) in flow cytometry analysis (intracellular staining) of human PHA stimulated and Brefeldin A treated peripheral whole blood stained with Anti-IL-17A Antibody [9F9] (A320757), (concentration in sample 0,5 µg/ml, GAM APC).
Publishing research using Anti-IL-17A Antibody [9F9] (A320757)? Please let us know so that we can list the citation on this page.
Alternative products to Anti-IL-17A Antibody [9F9] (A320757)
Recombinant humanized monoclonal antibody to IL-17A for use as a research grade Ixekizumab biosimila for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to IL-17A for use as a research grade Netakimab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to IL-17A for use as a research grade Secukinumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to IL-17A for use as a research grade Ixekizumab biosimila for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to IL-17A for use as a research grade Netakimab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to IL-17A for use as a research grade Secukinumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.